Market Intelligence Resource | December 4, 2021

The Role Of Psychedelics In Modern Psychiatry

This review of the evidence base for the use of psychedelics in psychiatry was given by Melissa Buboltz, M.D., Associate Professor of Psychiatry, OHSU; Aryan Sarparast, M.D., PGY-3 Psychiatry Resident, OHSU; D. Payton Sterba, M.D., PGY-3 Psychiatry Resident, OHSU; and Jovo Vijanderan, M.D., M.S., PGY-2 Psychiatry Resident, OHSU on October 17, 2019 at the Oregon Health & Science University . . .

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

About

Contact

Partnership

The Role Of Psychedelics In Modern Psychiatry

Tagged As:

About

Contact

Partnership

Markets

Services

Customers

Publications

Markets

Topics

Executive Institutes

Professional Development Programs

Tools

Assessments

Tagged As: